Author

Nicolas Rosa

University of GenevaORCID 0000-0003-4902-177XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Bita Asghariastanehei· 1 shared Cyril Castelbou· 1 shared Élie NaderiD· 1 shared Franciele de LimaiD· 1 shared Gorane Rodríguez-Urquirizar· 1 shared Hélène GuizouarniD· 1 shared José M. Fernández‐FernándeziD· 1 shared Lars KaestneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Bita Asghariastanehei

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintApr 30, 2026

Otenabant is a Selective Antagonist of Human PIEZO1

Vincent Jaquet, Reeta Penttinen, Gorane Rodríguez-Urquirizar…·Nicolas Demaurex

The paper identifies Otenabant, a CB1 antagonist, as a potent and selective PIEZO1 inhibitor through high-throughput screening and validates its effects across multiple assays.

DOI 10.64898/2026.04.28.720360

humanelectronic health records

𝕏 PostBluesky